NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

PCV13 Effectiveness Study Against Hospitalised VT Pneumococcal CAP in Adults 60 Years and Older

CompletedN/A

Sponsor: Pfizer

Conditions: Community Acquired Pneumonia (CAP)

Interventions: Urine sample collection, Saliva collection

Countries: Spain

Low interventional, prospective, multicentre, hospital-based study involving adults 60 years of age and older hospitalised with CAP at participating sites.

Eligibility overview

Sex: ALL

Age: 60 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

1. Age ≥60 years.
2. Evidence of pneumonia within first 48 hours of hospital admission
3. Evidence of a personally signed and dated informed consent document indicating that the patient (or a legally acceptable representative) has been informed of all pertinent aspects of the study.

Exclusion Criteria:

1. Any patient who develops signs and symptoms of pneumonia after being hospitalized for ≥48 hours (either at current hospital, another transferring hospital, or a combination of these).
2. Previously enrolled subjects readmitted ≤14 days after discharge for their study qualifying admission.
3. At the time of enrollment, pneumonia has been excluded as the diagnosis or another diagnosis confirmed.

Locations (5)

Getafe, Madrid, Spain
Leganés, Madrid, Spain
Alcorcón, Spain
Móstoles, Spain
Móstoles, Spain